Status:
COMPLETED
Optimal Metabolic Health Through Continuous Glucose Monitoring
Lead Sponsor:
University of South Florida
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
The primary focus of this study is to evaluate the role of Continuous Glucose Monitoring (CGM) with Levels Health software as a tool to provide feedback and accountability necessary to create sustaina...
Detailed Description
Achieving optimal metabolic health and glycemic control is a common goal among not only diabetics, but also for healthy individuals, athletes, elite military operators and for infectious disease preve...
Eligibility Criteria
Inclusion
- Ages 18-69 years of age
- Desire to improve metabolic health through nutritional, fitness, cognitive, and behavioral therapies.
- Voluntarily participate in either a live or virtual 12-week, multidisciplinary wellness program created and led by Allison Hull, DO.
- Body Mass Index (BMI) \> 20 kg/m2
- Fasting Blood Glucose (FBG) of 85-125 mg/dl
- HbA1c of 5.0-6.4 %
Exclusion
- Type 1 or 2 Diabetes.
- Chronic Kidney Disease
- End Stage Liver Disease
- Use of any weight loss medications currently or in the past 3 months.
- Disordered Eating - anorexia or bulimia nervosa.
- Pregnant or Breastfeeding females.
Key Trial Info
Start Date :
May 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2022
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT04920058
Start Date
May 10 2021
End Date
April 18 2022
Last Update
November 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida Medical Clinic
Wesley Chapel, Florida, United States, 33544